DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS The article highlights renewed emphasis on PSA testing as a baseline assessment tool while noting that interpretation increasingly focuses on PSA trends over time rather than a single value. It also reviews how multiparametric MRI and emerging blood and urine biomarkers may aid risk stratification before biopsy. The discussion emphasizes early detection while acknowledging that many men diagnosed with prostate cancer ultimately require surveillance rather than immediate treatment.
Patient Counseling Points
- PSA screening remains a starting point, but PSA values should be interpreted in the context of age, prostate characteristics, and longitudinal trends.
- An elevated PSA does not automatically indicate prostate cancer, and further evaluation may include MRI or additional biomarker testing.
- Not all elevated PSA findings require biopsy, as newer diagnostic approaches may help identify patients most likely to benefit from tissue sampling.
- Early-stage prostate cancer often produces no symptoms, making screening discussions important for eligible patients.
- A prostate cancer diagnosis does not automatically require surgery or radiation, as active surveillance remains appropriate for selected low-risk cases.
- Risk-based screening matters, particularly for Black men, individuals with family history, and those with inherited mutations such as BRCA-associated risk.
Patient Care Applications
- Discuss individualized screening timelines based on age, family history, ancestry, and hereditary risk factors.
- Clarify that PSA testing is one component of risk assessment rather than a standalone diagnostic determination.
- Reassure patients that elevated PSA values often require additional evaluation before invasive procedures are considered.
- Recognize opportunities to explain active surveillance as a management strategy for appropriately selected patients.
- Avoid framing prostate cancer screening as a simple positive-versus-negative decision process.
